Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating fezolinetant for reducing hot flashes in Chinese women going through menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Menopause

Drugs mentioned

• VEOZAH (fezolinetant)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED